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Stickler syndrome is characterized by ophthalmic, articular, orofacial, and auditory manifestations. It has an autosomal
dominant inheritance pattern and is caused by mutations in COL2A1, COL11A1, and COL11A2. We describe a family of
Moroccan origin that consists of four children with Stickler syndrome, six unaffected children, and two unaffectedparents
who are distant relatives (ﬁfth degree). All family members were clinically investigated for ear, nose, and throat; oph-
thalmologic; and radiological abnormalities. Four children showed symptoms characteristic of Stickler syndrome, in-
cluding moderate-to-severe sensorineural hearing loss, moderate-to-high myopia with vitreoretinopathy, and epiphyseal
dysplasia. We considered the COL9A1 gene, located on chromosome 6q13, to be a candidate gene on the basis of the
structural association with collagen types II and XI and because of the high expression in the human inner ear indicated
by cDNA microarray. Mutation analysis of the coding region of the COL9A1 gene showed a homozygous R295Xmutation
in the four affected children. The parents and four unaffected children were heterozygous carriers of the R295Xmutation.
Two unaffected children were homozygous for the wild-type allele. None of the family members except the homozygous
R295X carriers had any signs of Stickler syndrome. Therefore, COL9A1 is the fourth identiﬁed gene that can cause Stickler
syndrome. In contrast to the three previously reported Stickler syndrome–causing genes, this gene causes a form of
Stickler syndrome with an autosomal recessive inheritance pattern. This ﬁnding will have a major impact on the genetic
counseling of patients with Stickler syndrome and on the understanding of the pathophysiology of collagens. Mutation
analysis of this gene is recommended in patients with Stickler syndrome with possible autosomal recessive inheritance.
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Stickler syndrome was ﬁrst described in 1965 by Stickler
et al.1 and is characterized by ophthalmic, articular, oro-
facial, and auditory manifestations. Until now, it has been
reported as an autosomal dominant inherited syndrome
that is caused by mutations in COL2A1 (Stickler syndrome
type I [MIM 108300]), COL11A1 (Stickler syndrome type
II [MIM 604841]), and COL11A2 (Stickler syndrome type
III [MIM 184840]).2–4 Despite this heterogeneity, the ma-
jority of patients with Stickler syndrome have mutations
in the COL2A1 gene, which is positioned on chromosome
12q13.5,6
The most conspicuous manifestations in the syndrome
are ophthalmologic, including myopia, vitreoretinal de-
generation, cataracts, and, often, retinal detachment. It is
the most common inherited cause of rhegmatogeneous
retinal detachment in childhood.7 Typical facial changes
are midface hypoplasia, broad nasal bridge, micrognathia,
and cleft palate. These facial features often become less
pronounced with age. Osteoarthritis develops typically in
the 3rd or 4th decade. In most cases, there is radiographic
evidence of irregularity of articular surfaces suggestive of
epiphyseal dysplasia. Sensorineural, mixed, and conduc-
tive hearing loss has been reported, with conductive hear-
ing loss often a secondary effect of craniofacial anomalies.
Collagens are important in the maintenance of struc-
tural strength. In all tissues, collagen molecules are com-
posed of three polypeptide chains that have a triple-
stranded helical structure. On the basis of their function
and structure, collagens have been classiﬁed into ﬁbril-
forming collagens, ﬁbril-associated collagens, and col-
lagens that form structures unrelated to ﬁbrils. A further
subdivision can be made on the basis of the characteristics
of their precursor molecules.8
Currently, at least 40 different genes have been identi-
ﬁed that encode for at least 27 different collagens. In the
eye, collagens play an important role in the maintenance
of the three-dimensional structure that provides a correct
optical environment for vision. At least 22 different col-
lagens have been detected in the embryonic ormature eye.9
Six distinct collagen types seem to be characteristic of the
eye and cartilage and are absent in the majority of other
adult tissues. Most of the collagen ﬁbrils in the cartilage
and vitreous are heterotypic, containing more than one
collagen type. These collagens include types II, V/XI, VI,
IX, and XXVII. Types II, V/XI, andXXVII are ﬁbril-forming
collagens that mainly provide the structural strength of
the vitreous and cartilage. Type VI is a member of the
short-chain collagens that are thought to serve a function
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in stabilizing different ﬁbrillar structures. Type IX is one
of the ﬁbril-associated collagens with interrupted triple
helices (FACIT), which do not form ﬁbrils themselves but
are found attached to the surfaces of pre-existing ﬁbrils.10
Until now, only mutations in the ﬁbrillar collagen types
XI (encoded by COL11A1 and COL11A2) and II (encoded
by COL2A1) have been found to cause Stickler syndrome.
There is large clinical variability in Stickler syndrome,11
and no exact correlations exist with speciﬁc mutations. A
clinical subclassiﬁcation can be made on the basis of the
ocular phenotype. Mutations in COL2A1 and COL11A1
cause ocular signs, whereas mutations in COL11A2 do
not. This can be explained by the absence of COL11A2 in
the vitreous, where it is replaced by COL5A2.12,13 Patients
with COL2A1 mutations have a characteristic “membra-
nous,” or type I, vitreous phenotype, whereas patients
with COL11A1 mutations show a “beaded,” or type II,
vitreous phenotype.14
Type IX collagen ﬁbrils are regularly aligned along the
surface of the ﬁbrils composed of collagen types II and
XI.15 Mutations in all three collagen type IX genes have
been associated with autosomal dominant multiple epi-
physeal dysplasia, a relatively mild and clinically variable
osteochondrodysplasia, affecting ∼1 in 10,000 individuals
(for review, see the work of Briggs and Chapman16).
Type IX collagen is a FACIT, consisting of three col-
lagenous domains (COL1–COL3) interspersed among four
noncollagenous domains (NC1–NC4). Type IX collagen
ﬁbrils are heterotrimers of a1(IX), a2(IX), and a3(IX) chains
encoded by the COL9A1, COL9A2, and COL9A3 genes.17,
18 The collagen acts as a tissue stabilizer through interac-
tions between the ﬁbrillar surface and the extraﬁbrillar
matrix by its NC4 domain.19
Like the collagen types II and XI, type IX collagen is
also present in the cochlea20,21 but only in limited re-
gions—that is, in the cartilaginous rests of the enchondral
bone, the tectorial membrane, and the Reissner’s mem-
brane. Type XI collagen is mainly expressed in the same
structures as type IX collagen, except for the Reissner’s
membrane. At all places in the cochlea, type IX collagen
colocalizes with type II collagen.20 However, type II col-
lagen is also expressed in other structures, making it the
major protein in the cochlea.
We describe a family of Moroccan origin in which four
children have symptoms characteristic of Stickler syn-
drome. Mutation analysis of the COL9A1 gene was per-
formed on the basis of the structural association with col-
lagen types II and XI and because of the high expression
in the human inner ear indicated by cDNA microarray.22
Mutation analysis of theCOL9A1 gene, located on chromo-
some 6q13, showed a homozygous R295X mutation in
the four affected children. In contrast to the dominant
inheritance pattern of all previously described Stickler syn-
drome mutations, this family shows an autosomal reces-
sive inheritance pattern. The unaffected parents are dis-
tant relatives (ﬁfth degree) and are both heterozygous car-
riers of the R295X mutation.
Material and Methods
Clinical Examination
In this study, we investigated a Moroccan family with autosomal
recessive Stickler syndrome. All 12 family members (ﬁg. 1) were
investigated through general examination by specialists of ear,
nose, and throat; ophthalmology; radiology; and genetics. Vit-
reous examination and cycloplegic refraction were performed to
investigate the ophthalmologic phenotype. The audiologicalphe-
notype was investigated by measuring air and bone conduction
pure-tone audiometry. Radiographs were taken of the skull, the
spine, and the lower and upper extremities to investigate the
skeletal characteristics of all family members, including the par-
ents. Serum parameters were also investigated, including levels
of alkaline phosphatase, parathyroid hormone, calcium, phos-
phorus, creatinine, urea, and magnesium.
Genetic Analysis
Blood samples for DNA extraction were collected from all 12 fam-
ily members with informed consent. DNA was extracted from
leukocytes according to standardmethods. Primers were designed
for the ampliﬁcation of the coding region and exon-intron boun-
daries of the COL9A1 gene. Sequencing of the PCR products was
performed by standard procedures and was analyzed on an ABI
3110 DNA sequencer (Applied Biosystems).
Audiological Examination
Pure-tone air and bone thresholds were determined at frequencies
of 250, 500, 1,000, 2,000, 4,000, and 8,000 Hz, with intensities
up to 120 dB. The pure-tone average (PTA) was calculated for all
family members, by use of the average of the hearing thresholds
at 500, 1,000, and 2,000 Hz.
Results
General Examination
All family members had normal blood parameters, except
for family member II.2. The serum parameters of II.2 were
consistent with a known diagnosis of hypophosphatemic
rickets. A general characteristic of the family was the rel-
atively short stature of all family members. Most children
were between the 10th and 25th percentiles. Remarkably,
the height of all patients (II.3, II.8, II.9, and II.10) was
!3rd percentile. This short stature was not disproportion-
ate, and no severe abnormalities in the skeletonwerenoted.
The height of II.2 was also !3rd percentile, most likely be-
cause of the hypophosphatemic rickets. Unaffected family
member II.4 was also very short (∼3rd percentile). All pa-
tients had genua valga. Patient II.8 had a Beighton score
of 7 (out of 9 total), indicating hypermobility of the joints.
The oldest patient, II.3, had painful knees, which may in-
dicate arthritis. All family members showed a relatively
ﬂat face, which was not more pronounced in the affected
family members (ﬁg. 2). None of the patients was born
with a cleft palate or micrognathia.
Audiology
The best PTA value at 500, 1,000, and 2,000 Hz for every
individual is shown in ﬁgure 1. The father had normal
Figure 1. Pedigree of the family with autosomal recessive Stickler syndrome. Blackened symbols represent individuals with Stickler syndrome, and unblackened symbols represent
individuals with a normal phenotype. Individual II.2 is a girl with hypophosphatemic rickets thought to be unrelated to Stickler syndrome. For all family members, the age when
the clinical investigations were performed; the genotype; the PTA, or Fletcher index (FI), of the better ear; and the refractions for the right (R) and left (L) eyes are given below
each symbol. For the affected individuals, extra clinical data on the ophthalmologic and radiological ﬁndings are also shown. wt p wild type; y p years.
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Figure 2. A, Pictures of the four affected family members. The height of all patients is !3rd percentile. They all have a relatively ﬂat
face. All patients wear glasses because of amblyopia with high myopia and astigmatism. They all have genua valga. B, Pictures of the
six unaffected children. The facial features between unaffected and affected individuals are indistinguishable.
hearing for his age ( dB), with a bilateral sen-PTAp 16.6
sorineural dip at 4,000 Hz (ﬁg. 3B), probably caused by
known professional noise exposure. The mother (age 46
years) had mild hearing loss ( dB), with a ﬂatPTAp 21.6
audiometric conﬁguration of unknown origin (ﬁg. 3B).
The four heterozygous carriers of the mutation (II.2, II.4,
II.5, and II.7) and the two homozygous wild-type children
(II.1 and II.6) did not have any hearing loss (ﬁg. 3B). All
four patients (II.3, II.8, II.9, and II.10) had moderate-to-
severe hearing impairment, with a mildly down-sloping
audiogram (ﬁg. 3A). No air-bone gap was present in pa-
tients II.3, II.9, and II.10, which points to sensorineural
hearing loss. Air and bone audiograms were symmetrical
in these three patients. The air conduction threshold of
the left ear of patient II.8 was below the bone conduc-
tion level in that ear ( dB), but the bone con-PTAp 105
duction levels of this patient were symmetrical in both
ears ( dB). The asymmetrical hearing loss wasPTAp 51.6
due to chronic otitis media in the left ear.
Two earlier audiograms were available for patients II.3
and II.8, taken 6 years before this study. The progression
of the PTA values in these patients was 1.4 dB/year. How-
ever, this limited information did not allow a deﬁnitive
conclusion about the progression of hearing loss in all four
patients.
Ophthalmologic Findings
The four patients showed amblyopia with moderate-to-
highmyopia and astigmatism. The refractions for the right
and left eyes for all family members are included in ﬁgure
1. All patients presented vitreous changes consisting of
syneresis of an optically empty vitreous with some ﬁbrillar
condensates. Important to note was that the vitreous phe-
notype did not resemble the membranous, beaded, and
nonﬁbrillar phenotypes that have been described else-
where for Stickler syndrome. It resembled an aged vitre-
ous, the composition of which is degenerated because of
progressive gel liquefaction. Patients II.3 and II.10 had
normal retinas, whereas patients II.8 and II.9 showed ret-
inopathy. Atrophic retinal holes were noted in the left eye
of patient II.9, whereas patient II.8 exhibited circumferen-
tial and perivascular pigmentary degeneration of the ret-
ina. The mean (SD) refractive power of the ocular lens
of the four patients was signiﬁcantly higher (26.9 2.83
diopters [D]) than that of the other family members (18.5
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Figure 3. A, Most-recent air conduction thresholds of the better
ear for each of the four patients. The hearing loss is moderate to
severe, with a mildly down-sloping audiogram. B, Air conduction
thresholds of the better ear for each of the parents (bold lines)
and unaffected children. The father has normal hearing for his
age, with a bilateral sensorineural dip at 4,000 Hz, probably caused
by known professional noise exposure. The mother has mild hearing
loss of unknown cause. None of the unaffected children has hearing
loss.
 1.79 D). None of the unaffected family members dem-
onstrated vitreous alterations, signiﬁcant refractive error,
or high refractive power of the lens or amblyopia.
Radiological Findings
The radiological features observed in all four patients var-
ied, but, in general, they were rather subtle (ﬁg. 4). The
two youngest patients (II.9 and II.10) had the most pro-
nounced radiological features. They had mild hypoplasia
of the maxilla, whereas the maxilla was radiologicallynor-
mal in the two oldest patients. This may be explained by
the fact that midface hypoplasia often becomes less con-
spicuous with advancing age. The femoral epiphyses of
patients II.9 and II.10 were ﬂattened and irregular, and the
femoral necks were very broad and relatively short. The
oldest patient (II.3, age 20 years) showed dysplasia of the
femoral head, with a relative broadening of the femoral
neck. Remarkably, patient II.8 did not have any radio-
graphic femoral abnormalities. The four patients showed
ﬂattened epiphyses of metacarpals II–V. Patient II.3 showed
platyspondyly of the midthoracic spine. Eight members
of the family (all members except I.2, II.5, II.9, and II.10)
showed irregular delineation of the vertebral end plates,
resembling Scheuermann disease. This spinal abnormality
has been associated with Stickler syndrome.23 However,
since patients, carriers, and noncarriers in this family had
Scheuermann-like changes, the changes were probably not
associated with Stickler syndrome in this family.
Genetic Analysis
The family was incorporated into an ongoing project in
which mutation analysis was performed on genes with
high expression in the inner ear, including COL9A1. Nei-
ther a linkage genome scan nor an analysis of other Stick-
ler syndrome genes was done. Sequencing of all COL9A1
coding exons in patients II.9 and II.10 revealed homo-
zygous nonsense mutation R295X in exon 9, which en-
codes for the ﬁrst triple-helix repeat domain of COL9A1.
The mutated exon 9 was sequenced in all other family
members. The four affected individuals (II.3, II.8, II.9, and
II.10) were homozygous for the mutation, and both par-
ents and four unaffected children (II.2, II.4, II.5, and II.7)
were heterozygous. The mutation was not found in two
family members (II.1 and II.6) and in 100 random Belgian
control persons. One other sequence variant, c.1862ArG,
was identiﬁed in exon 28 of the gene, but this variant
has already been reported as polymorphism rs1135056
(dbSNP).
Discussion
COL11A2 is the only Stickler syndrome–causing gene in
which homozygous mutations have been reported. These
mutations are almost all predicted to cause complete ab-
sence of a2(XI) chains and to cause otospondylomega-
epiphyseal dysplasia (OSMED)24 and, recently, also non-
syndromic hearing impairment (DFNB53).25 This is a skel-
etal dysplasia accompanied by severe hearing loss. The
phenotype overlaps Stickler syndrome but can be distin-
guished by disproportionately short limbs, severe hearing
loss, and lack of ocular involvement. Also, in this family
with recessive Stickler syndrome, the nonsense mutation
R295X will probably lead to absence of type IX collagen.
The milder skeletal and auditory phenotype, in compari-
sonwithOSMED, can be explained by the fact thatCOL9A1
is a FACIT and not a ﬁbril-forming collagen.
Mutations in all three collagen type IX genes result in
multiple epiphyseal dysplasia. All mutations in COL9A2
and COL9A3 are clustered at the splice-site junctions of
exon 3.18,26–30 This results in an aberrant mRNA with an
in-frame 36-bp deletion of exon 3 and produces a protein
lacking 12 aa from the COL3 domain. There is only a
single mutation in COL9A1 that causes multiple epiphys-
eal dysplasia (MED). It is a splice-site mutation that results
in an in-frame deletion of exon 8 and/or exon 10.31 Since
COL9A1 contains six additional exons, compared with
COL9A2 and COL9A3, exon 9 of COL9A1 corresponds to
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Figure 4. A, Standard radiograph of the hands and wrists of individual II.3 at age 20 years. Flattening, underdevelopment, and
squaring of the heads of the metacarpal bones, particularly at metacarpal IV bilaterally, are indicated (arrows). Also note bilateral
clinodactyly as an incidental ﬁnding. B–E, Radiographs of individual II.9 at age 10 years. B, Standard radiograph of the pelvis. Flattening
and irregular delineation of the left femoral epiphysis are indicated (arrow). Also note the broadening of the femoral neck, particularly
at the left side. C, Standard radiograph of the hands and wrists. Subtle ﬂattening and squaring of the metacarpal heads are indicated
(arrows). D, Standard radiograph of the left knee and lower leg. Note slight overtubulation and narrowness of the diaphyses of the
femur, tibia, and ﬁbula. E, Detail of the left tibia and ﬁbula. F, Standard radiograph of the pelvis of individual II.10 at age 7 years.
Slight ﬂattening and irregularity of the femoral epiphyses are indicated (arrows). Also note the broadening of the femoral neck,
particularly at the left side (asterisk [*]). G, Spot view of the slightly ﬂattened and irregular left femoral epiphysis of individual II.10.
exon 3 in the other two COL9 genes. Therefore, it was
surprising that the splice-site mutation in COL9A1 that
causes MED did not result in skipping of exon 9. The
reason why mutations group around the donor/acceptor
sites of exon 3 in COL9A2 and COL9A3 and around exon
8 in COL9A1 is not yet clear. It is plausible that the re-
sulting deletion of amino acids from this domain of type
IX collagen may disrupt interactions with other compo-
nents of the cartilage. This may be caused by the deletion
of a binding site within the COL3 domain. Another pos-
sibility is that the orientation of the a1(IX) NC4 domain
relative to the type II/XI collagen ﬁbril is changed by the
mutation.
In the vitreous type IX collagen is a proteoglycan with
a single chondroitin sulphate side chain covalently linked
to the collagenous protein core.32 This side chain may be
important for the maintenance of spacing between adja-
cent collagen ﬁbrils.33,34 It was shown that type IX collagen
shields type II collagen from exposure to the surface of
the vitreous ﬁbrils.35 With aging, the vitreous collagen ﬁ-
brils are predisposed to fusion, because of the diminished
shielding due to loss of type IX collagen. These changes
are thought to underlie vitreous liquefaction and weak-
ening of vitreoretinal adhesion. Because type IX colla-
gen is most likely not present in the patients of the fam-
ily studied here, the ﬁbrillar collagens in their vitreous
may not be shielded, possibly resulting in a rapidly aging
vitreous due to liquefaction and degeneration. It is not
surprising that this vitreous phenotype has not been de-
scribed previously in patients with Stickler syndromewith
collagen type II or XI mutations, because of the different
function of type IX collagens compared with the ﬁbril-
forming collagen types II and XI.
All three genes that elsewhere were shown to cause au-
tosomal dominant Stickler syndrome have been studied
extensively by the creation of transgenic mice. Homo-
zygous COL2 knockout mice died perinatally with severe
chondrodysplasia. The chondrodysplasia (cho) mouse
model is a functional null allele of Col11a1 that causes
lethal chondrodysplasia in cho/cho newborn mice and os-
teoarthritis in cho/ heterozygotes.36 In humans, no re-
cessive diseases are known to be caused by COL2A1 and
COL11A1. Similar to the homozygous knockout mice of
these genes, homozygosity in humans might not be com-
patible with life. Both homozygous and heterozygous
Col11a2 knockout mice had hearing loss due to disorga-
nized collagen ﬁbrils in the tectorial membrane.37 Inter-
estingly, the phenotype of the Col11a2 knockoutmicewas
milder than that of the cho/cho mice.
A functional knockout mouse of the Col9a1 gene has
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Table 1. Ocular Symptoms in Stickler Syndrome Caused
by Mutations in Different Collagen Genes
Gene Ocular Symptoms
COL2A1 Membranous or type I vitreous phenotype, aﬁbrillar phenotype
COL11A1 Beaded or type II vitreous phenotype
COL11A2 No ocular symptoms
COL9A1 Vitreous syneresis with an optically empty vitreous due to
progressive gel liquefaction
been created.38 The animals did not produce a1(IX)mRNA
and were born without conspicuous skeletal abnormali-
ties. However, they developed early-onset osteoarthritis.
Histological analysis of the eyes did not show apparent ab-
normalities, even in older animals with articular changes.
The deﬁciency in a1(IX) chains was shown to lead to a
functional knockout of all three chains of collagen type
IX.39 Therefore, the synthesis of a1(IX) polypeptides is es-
sential for the assembly of heterotrimeric collagen type IX
molecules. Although the knockout mice lacked collagen
type IX, they had normal cartilage ﬁbrils and banding
patterns. Therefore, it was proposed that collagen type IX
is not essential and may be functionally redundant in the
ﬁbrillinogenesis in cartilage.39 The auditory function of
the Col9a1 knockout mice, however, was impaired. We
recently showed that homozygous a1(IX) collagen knock-
out mice had progressive hearing loss that was due to the
disorganization of the collagen ﬁbres.40
Early recognition of the Stickler syndrome phenotype
is important for accurate counseling and possible treat-
ment. Treatment includes cryotherapy and laser therapy
for retinal detachment, the use of hearing aids, and joint
replacements. The patients in this Moroccan family did
not show cataract or retinal detachment that needed sur-
gical treatment, but close ophthalmologic follow-up will
be necessary, since atrophic retinal holes and pigmentary
degeneration of the retina were already present in patients
II.8 and II.9, respectively. Progressive degeneration of the
vitreous results in a collapse of the entire gel-like structure.
As a consequence, the vitreous is detached ﬁrst from the
areas of the weakest attachments, located at the posterior
retina and optic nerve. In areas of ﬁrm localized attach-
ments, retinal holes or retinal ruptures develop. Because
of the young age and the lack of early follow-up of the
affected siblings in this family, the risk of rhegmatoge-
neous retinal detachment cannot be determined yet. It
also could not be traced whether the refractive error was
congenital or developed during childhood. They all had
bilateral amblyopia that probably was due to uncorrected
refractive anomaly during early childhood, because no
macular abnormalities were observed. The abnormalities
in the ocular lens power that were seen in this family have
not been reported elsewhere in Stickler syndrome.
In conclusion, COL9A1 is the fourth identiﬁed gene that
can cause Stickler syndrome. In contrast to the three pre-
viously identiﬁed Stickler syndrome–causing genes, this
gene causes a form of Stickler syndrome that has an auto-
somal recessive inheritance pattern. This ﬁnding will have
a major impact on the genetic counseling of patients with
Stickler syndrome and on the understanding of the path-
ophysiology of collagens. Mutation analysis of this gene
is recommended for patients with Stickler syndrome with
possible autosomal recessive inheritance. In addition, the
ophthalmologic examination of patients with clinical
symptoms and signs of Stickler syndrome could be used
as themain distinction among the different collagengenes
known to cause this syndrome (table 1). The vitreous phe-
notype on its own, however, is not always conclusive for
deciding which gene caused the Stickler syndrome. Par-
entin et al.41 reported a patient with a type I vitreous phe-
notype for which linkage to COL2A1 could be excluded.
Linkage to COL11A1, however, was not convincing, since
the LOD score at was only 0.58. McLeod et al.42vp 0
reported a patient with a mutation in COL2A1 in whom
the vitreous phenotype shifted from type II to type I. The
ﬁrst child of this patient showed a type I vitreous phe-
notype in the left eye and a type II phenotype in the right
eye. The clinical observations in both articles could be
explained by posterior vitreous detachment. However,
these reports show that the vitreous phenotype should be
interpreted with caution.
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